Skip to main content
ChoA Pharmaceutical Co., LTD. logo

ChoA Pharmaceutical Co., LTD. — Investor Relations & Filings

Ticker · 034940 ISIN · KR7034940007 KO Manufacturing
Open in API
Filings indexed 115 across all filing types
Latest filing 2019-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 034940

About ChoA Pharmaceutical Co., LTD.

https://www.choa.co.kr/en/

ChoA Pharmaceutical Co., LTD., established in 1988, is a company engaged in the development, manufacturing, and sale of pharmaceutical products and health supplements. The company's portfolio comprises approximately 200 products, including over-the-counter (OTC) drugs, generic medications, and functional health foods. It offers a diverse range of formulations such as tablets, capsules, granules, ampoules, and a notable selection of liquid and drinkable products. ChoA Pharmaceutical primarily supplies pharmacies and maintains a global business presence, exporting its products to more than 20 countries. The company focuses on developing high-quality medicines and health-related products to contribute to public well-being.

Recent filings

Filing Released Lang Actions
분기보고서 (2019.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for Cho-A Pharmaceutical Co., Ltd. for the period ending March 31, 2019. It contains comprehensive financial statements, management discussion, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-15 Korean
사업보고서 (2018.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive 'Audit Report' (연결감사보고서) for Joa Pharmaceutical Co., Ltd. for the fiscal year 2018. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of comprehensive income, statement of changes in equity, cash flow statement), and detailed notes. While it contains financial data, it is the formal audit report rather than a 10-K (which is a specific US regulatory filing) or a simple earnings release. Given the structure and content, it fits the 'Audit Report / Information' category. FY 2018
2019-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official filing titled '정기주주총회결과' (Results of the Annual General Meeting) for Cho-A Pharm. It details the outcomes of the meeting, including the approval of financial statements, dividend resolutions, and board/management appointments. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements.
2019-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed with the Korean Exchange (KRX). It provides the auditor's opinion (적정 - Unqualified), financial highlights for the current and previous fiscal years, and confirms the receipt of the audit report. While it contains financial data, it is a regulatory disclosure announcement regarding the filing of the audit report rather than the full 10-K annual report itself. Therefore, it is classified as an Audit Report/Information document. FY 2018
2019-03-14 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Proxy Solicitation' (위임장 권유) filed by Cho-A Pharm Co., Ltd. for its 23rd Annual General Meeting. It contains detailed information regarding the meeting agenda, including proposed amendments to the Articles of Incorporation and approval of director remuneration limits, which are standard components of a proxy statement used to solicit shareholder votes. It is not a report publication announcement, but rather the proxy materials themselves.
2019-03-05 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Cho-A Pharmaceutical Co., Ltd. It details the meeting date, location, agenda items (financial statements, director compensation, and articles of incorporation amendments), and voting procedures (including electronic voting). This document is a formal proxy statement/notice sent to shareholders to inform them of an upcoming meeting and solicit their votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2019-03-05 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.